SoloHealth recently announced a new relationship with WellPoint to help provide consumers with convenient access to information about their health and wellness through the next- generation SoloHealth Station consumer kiosks.
The news comes on the heels of SoloHealth Station’s recent Food and Drug Administration approval in June, as well as its announcement of an aggressive rollout to retail locations nationwide to begin this fall.
The SoloHealth Station is an interactive, comprehensive health-and-wellness screening kiosk for consumers that is placed in high-traffic retail locations or high-volume places like corporate campuses or hospitals. “We’re really taking health care to where the people are,” Bart Foster, SoloHealth CEO, told Drug Store News. The SoloHealth Station provides health screenings for vision, blood pressure, weight and body mass index, a symptom checker and an overall health assessment free of charge. SoloHealth also helps connect consumers to local professionals through their databases, helping people enter the most appropriate and accurate point in the healthcare system.
With this kiosk in mind, SoloHealth was one of the companies invited to testify before the FDA’s public meeting on ways to expand the Rx-to-OTC switch paradigm. The kiosk can help to drive awareness around a particular condition or remedy, can help educate the consumer and spark action, Foster said. “It’s precisely in the sweet spot of what the FDA is trying to do,” he said.
“We have a long-standing commitment to help people get healthy and stay healthy by leveraging consumer-friendly products and services to improve their health and wellness,” stated Brett Moraski, VP transformation for WellPoint. “SoloHealth’s consumer kiosk ... is a truly innovative product that leverages technology to provide an enhanced, convenient and engaging consumer health experience. By investing in SoloHealth, we are excited to help millions of Americans better manage their own health and well-being.”